-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/hook.json
January 01, 2023 - {
"hook": "patient-view",
"title": "CTPA order check",
"description": "CTPA order check cds hook",
"id": "pe",
"prefetch": {
"patient": "Patient/{{context.patientId}}",
"wells": "Observation?subject={{context.patientId}}&code=http://loinc.org|89547-4",
"ddimer": "Observation?subject={{cont…
-
cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
January 01, 2017 - Title of document or resource
Repository Work Group
Meeting Summary
Date
03/08/2017
Time
1:30 – 3:30 PM ET
AGENDA
· Clarify Details Related to Existing Artifacts
· Logic exclusions, specification of conditions, lookback periods and the inclusion of parameters for scalar values
· Considerations for art…
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
04/19/2017
Time
01:00 – 3:00 PM EST
AGENDA
· Welcome
· Brief Overview of Existing CDS Connect Artifacts
· Clarify Logic Details for USPTF-related Artifacts
· Discuss Best Approach for Transforming eCQM Specifications into CDS Logic
· Next Steps an…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - delaying progression to
diabetes in certain populations but has not secured FDA approval for this indication
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
October 17, 2018 - Either there is an indication that the recommended dosing
sequence was not followed (i.e., there is … populated, then the evaluators marked that entry in the form shown in Appendix A.1
with a “1” as an indication
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - Cholesterol Management Work Group recommendation based on their medical expertise), and active dialysis is an indication
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/CQL%20to%20CDS%20Hooks%20cards_0.txt
January 01, 2023 - Mapping of CQL conditions to CDS Hooks cards
Condition: NoDDimerNoWells
Card: It is recommended to assess the patient's risk for pulmonary embolism (PE) and evaluate D-dimer levels before proceeding with a CTPA order. Use the following link to evaluate the risk.
Launch Questionnaire: Yes
Condition: NoDDimerWellsLessT…
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
June 07, 2019 - If there is an indication that the patient
cannot tolerate a particular recommended treatment, an
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ)
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
January 01, 2024 - A result of >130 mg/dL is an indication of dyslipidemia. … A result of <40 mg/dL is an indication of dyslipidemia.
-
cds.ahrq.gov/sites/default/files/cds/artifact/106/AMIA_presentation.pptx
January 01, 2012 - PowerPoint Presentation
Decision Support to Improve Childhood
Obesity Management
Jeremy Michel, MD, MHS
Physician-Informatician
The Children’s Hospital of Philadelphia & ECRI Institute
1
Disclosures
Work I will be discussing was indirectly funded by the American Beverage Foundation through an unrestricted grant t…
-
cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
January 01, 2021 - CDS Connect Work Group June 2021 Summary
CDS (Clinical Decision Support) Connect Work Group
Meeting Summary
June 17, 2021
3:00-4:00 pm ET
Attendees: 41 people, including 3 phone dial-ins
Organization Attendee Names
AHRQ Sponsors Edwin Lomotan; Mario Teran; Roland Gamache; Steve Bernstein (4)
Work Group…
-
cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Summary.pdf
January 01, 2022 - April 2022 CDS Connect Work Group Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
April 21, 2022
3:00 – 4:00 pm ET
Attendees: 31 people, including 6 phone dial-ins
Organization Attendees
AHRQ Sponsors Edwin Lomatan, Mario Teran, Roland Gamache (3)
WG Members Alex Go…
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - A result of >130 mg/dL is an
indication of dyslipidemia, a risk factor for developing coronary artery … A result of <40 mg/dL is an indication of dyslipidemia, a
risk factor for developing CAD and stroke.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
January 01, 2024 - Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening
Implementation Guide
Prediabetes and Type 2 Diabetes:
Part One, Screening
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contract No. 75FCMC18D0047
Prepared by:
CMS Alliance to Moder…
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
02/08/2017
Time
1:30 – 3:30 PM ET
AGENDA
· Welcome
· Discuss Remaining Repository Questions
· Clarify 10-Year Risk Assessment Details
· Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact
· Discuss Next Artifacts for Developmen…
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ) Error! No text of specified style in document.
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk
Prepared for:
Agency for Healthcare Re…
-
cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdf
January 01, 2021 - June 2021 CDS Connect Work Group Slides
June 2021 CDS Connect Work Group Call
Meeting Agenda
Schedule Topic
3:00 - 3:02 • Roll Call, Michelle Lenox (MITRE)
3:02 - 3:05 • Review of the Agenda, Maria Michaels (CDC)
3:05 - 3:50
• Using CDS to Reduce Harm From Drug-Drug Interactions:
Case Study of Warfarin and N…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - A result of
>130 mg/dL is an indication of dyslipidemia, a risk factor for developing
coronary artery … A result of <40 mg/dL is an
indication of dyslipidemia, a risk factor for developing CAD and stroke.
-
cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
January 01, 2016 - Cholesterol Management Work Group
Meeting Summary
Date
12/09/16
Time
2:00 – 4:00 PM EST
AGENDA
· Welcome and Introductions
· CDS Connect Project Overview
· CDS Cholesterol Management Work Group Overview and Planning
· CDS Cholesterol Management Environmental Scan Findings and Artifacts
· CDS Cho…